Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 6, Pages 1760
Publisher
MDPI AG
Online
2023-03-15
DOI
10.3390/cancers15061760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
- (2021) Alison J. Moskowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
- (2021) Isabelle Demeestere et al. JOURNAL OF CLINICAL ONCOLOGY
- PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
- (2021) Stefanie Kreissl et al. Lancet Haematology
- Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience
- (2021) Muhammad Saad Hamid et al. Clinical Lymphoma Myeloma & Leukemia
- Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
- (2020) David J. Straus et al. BLOOD
- 2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma
- (2020) M. Picardi et al. EUROPEAN JOURNAL OF CANCER
- Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio
- (2019) Mathieu N. Toledano et al. PLoS One
- Five-Year Follow-up of SWOG S0816: Limitations and Values of a PET-Adapted Approach for Stage III/IV Hodgkin Lymphoma
- (2019) Deborah M Stephens et al. BLOOD
- Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?
- (2019) Mattia Novo et al. LEUKEMIA & LYMPHOMA
- PET-adapted therapy for advanced Hodgkin lymphoma – systematic review
- (2018) Irina Amitai et al. ACTA ONCOLOGICA
- Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
- (2018) Valeria Spina et al. BLOOD
- Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
- (2018) Andrea Gallamini et al. JOURNAL OF CLINICAL ONCOLOGY
- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma
- (2018) Carsten Kobe et al. SEMINARS IN NUCLEAR MEDICINE
- Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial
- (2018) Richard A Anderson et al. LANCET ONCOLOGY
- Monitoring response in lymphomas: qualitative, quantitative, or what else?
- (2018) Alberto Biggi et al. LEUKEMIA & LYMPHOMA
- FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
- (2017) Sally F. Barrington et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET)
- (2016) Salvatore Annunziata et al. ANNALS OF NUCLEAR MEDICINE
- Interim Positron Emission Tomography Response–Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study
- (2016) Pier Luigi Zinzani et al. JOURNAL OF CLINICAL ONCOLOGY
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
- (2016) Peter Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma
- (2014) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- qPET – a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma
- (2014) Dirk Hasenclever et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
- (2013) A. Biggi et al. JOURNAL OF NUCLEAR MEDICINE
- Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients
- (2011) Pier Luigi Zinzani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma
- (2010) J. J. Cerci et al. JOURNAL OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now